Page 5 - University of Texas Health Science Center at San Antonio

Neuroscience

In the quest for a TBI therapy, astrocytes may be the bull's-eye

Growing evidence suggests that traumatic brain injury (TBI) is an important risk factor for developing Alzheimer's disease and dementia. But to date, effective therapies aren't available for preventing or treating TBI-induced ...

Oncology & Cancer

RNA 'heroes' can disarm bad-actor proteins in leukemia: study

Scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) believe it may be possible to prevent DNA changes driven by two proteins highly active in leukemia and other cancers. They ...

Diseases, Conditions, Syndromes

Immune memory less durable after severe COVID-19, study suggests

Infection-fighting B cells retain better memory of the coronavirus spike protein in University Hospital patients who recover from less-severe cases of COVID-19 than in those recovering from severe COVID-19, a new study suggests. ...

Neuroscience

Autism-linked gene, if deleted, results in less myelin

Myelin, a sheath of insulation around nerves that enables electrical impulses to efficiently travel through the central nervous system, is diminished in mice that have a gene deletion associated with autism spectrum disorder, ...

Neuroscience

Visuals increase attention; now science explains why

"Look at me!" we might say while attempting to engage our children. It turns out there is a neurochemical explanation for why looking at mom or dad actually helps kiddoes pay better attention.

Oncology & Cancer

94% of patients with cancer respond well to COVID-19 vaccines

In a U.S. and Swiss study, nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose, but the fact that a small group of the patients ...

page 5 from 19